RxDoctor Payments Data

Xiaohui Fan, MD

Pain Medicine · Farmington, MONPI 1245276252

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 54.3% of the total. Reporting peaked in 2022 at $853 and has fallen 60.3% since, to $338 in 2025.

$4,147in general payments, 2019–2025

Across 227 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$404
  • Pfizer$283
  • Novo Nordisk$189
  • Scilex Pharmaceuticals Inc.$170
  • Abbott$146
  • plus $703 from 18 others

What the payments were for

  • Food & beverage$4,147100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,147 in reported general payments places this provider in the 60th percentile of 124 pain medicine providers in Missouri.

See all pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$253,335
Medicare patients
385
Services billed
9,741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,023$30,155
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen550$14,508
Tramadol Hcl547$5,902
Pregabalin208$5,309
Oxycodone Hcl131$3,099
Acetaminophen-CodeineAcetaminophen With Codeine101$2,529
Gabapentin121$1,549
Naloxone Hcl20$1,255
Morphine Sulfate ErMorphine Sulfate40$869
Tizanidine Hcl65$708
Carisoprodol23$639
Cyclobenzaprine Hcl24$270
Baclofen16$268
Amitriptyline Hcl25$212
Celecoxib16$179

Paid to pharmacies, not to this prescriber.

Other pain medicine in Farmington

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →